ライフサイエンスコーパス: nonsensitized

1 osomes from sensitized mothers compared with nonsensitized.

2 patients were sensitized to egg (69%) and 60 nonsensitized (31%).

3 ification of patients with CF into 3 groups: nonsensitized, A fumigatus-sensitized, and ABPA.

4 Nonsensitized and A. fumigatus-sensitized CBA/J mice rec

5 hat the response to acute methamphetamine in nonsensitized and saline-treated animals may be function

6 responses to prefrontal cortex activation in nonsensitized and saline-treated animals, but not in sen

7 g) abolished accumbens up and down states in nonsensitized and saline-treated animals, suggesting a d

8 effect of triplet matching was seen for both nonsensitized and sensitized patients and also for white

9 e behavioral distinction between sensitized, nonsensitized, and control rats in behavioral responsive

10 r activity than did the saline-pretreated or nonsensitized animals after AMPA injection into either s

11 In sensitized, but not in nonsensitized animals, virus-induced hyperresponsiveness

12 rway eosinophilia and AHR when compared with nonsensitized animals.

13 effect on cocaine-induced motor activity in nonsensitized animals.

14 timulated glucose responses in comparison to nonsensitized animals.

15 nsiveness to methacholine when compared with nonsensitized animals.

16 reactivity in sensitized animals, but not in nonsensitized animals.

17 ed for the ability to induce ACAID in naive (nonsensitized) as well as T- and B-cell-deficient recipi

18 e lowest rate of allograft survival, whereas nonsensitized Asians had the highest survival.

19 tions contribute to normal gastrulation in a nonsensitized background.

20 Patients were considered sensitized or nonsensitized based on the frequencies of HLA-specific B

21 the apoptotic process compared with that in nonsensitized cells.

22 greater risk of developing viral wheeze than nonsensitized children (hazard ratio [HR], 1.9; 95% conf

23 a limited number of allergens suggested that nonsensitized children produce IgG responses mainly to f

24 ean levels of IgG to allergenic molecules in nonsensitized children were lower at age 2 years than in

25 n response to purified allergens compared to nonsensitized children.

26 Compared with nonsensitized class, children in the class with sensitiv

27 actions take place under both sensitized and nonsensitized conditions, and they are highly stereosele

28 irradiation, with comparison to samples from nonsensitized control cultures.

29 vely expressed in lung tissue collected from nonsensitized control mice but increased levels were fou

30 ith (n = 55) or without (n = 17) asthma, and nonsensitized controls (n = 20).

31 and egg-sensitized 14-month-old infants and nonsensitized controls enrolled in HealthNuts, a populat

32 ntly greater in BCG responders compared with nonsensitized controls, indicating that BCG vaccination

33 nuated in EtOH-sensitized mice compared with nonsensitized counterparts.

34 Nonsensitized DO11.10 mice but not wild-type mice respon

35 In contrast, nonsensitized effector CD8 T cells responded robustly to

36 eotaxin-injected, 8.6 +/- 1.0 x 10(5)) than nonsensitized, eotaxin-injected mice (2.5 +/- 0.4 x 10(5

37 (c) Low-risk patients (nonsensitized first transplantation) should be screened

38 wed hyperacute or acute humoral rejection in nonsensitized GalT KO mice with low levels of anti-alpha

39 in independent groups of EtOH-sensitized and nonsensitized genetically heterogeneous female mice afte

40 ar survival was 67% (95% CI, 0.5-0.8) in the nonsensitized group and 64% (95% CI, 0.3-0.9) in the sen

41 ere were six renal allograft failures in the nonsensitized group but none in the sensitized group.

42 the first injection of daily cocaine, and a nonsensitized group showing < 20% elevation.

43 ansplantation were similar: 1.5 mg/dL in the nonsensitized group versus 1.36 mg/dL in the sensitized

44 anti-Ova IgE levels that were similar to the nonsensitized group.

45 was no difference between the sensitized and nonsensitized groups (P>0.4 for all) in usage of blood p

46 similar levels of CTA in EtOH-sensitized and nonsensitized groups.

47 duced hyperreactivity and M2R dysfunction in nonsensitized guinea pigs.

48 Among 267 nonsensitized heart transplant recipients, switching fro

49 a are quickly eliminated from the airways of nonsensitized individuals but persist in individuals wit

50 ent exacerbation of asthma, possibly even in nonsensitized individuals.

51 Of the 383 nonsensitized infants (56.7% male), 184 were randomized

52 IL-12p70 and lower IL-10 levels compared to nonsensitized infants.

53 Antigen Flow Bead assays, 346 pretransplant nonsensitized kidney recipients were screened at 2 and 5

54 dneys at 8 years was significantly better in nonsensitized (<20% panel reactive antibodies; 68% vs. 5

55 Fifty-five previously nonsensitized LVAD recipients of a TCI device implanted

56 ved by 1 h after challenge of sensitized and nonsensitized mice and was dependent on TNF-alpha.

57 e levels observed in skin challenge sites of nonsensitized mice but rose to a second peak 12 h after

58 tent airway alterations were not observed in nonsensitized mice challenged with A. fumigatus conidia

59 ministration of anti-MCP-1/CCL2 antiserum to nonsensitized mice for14 days after the conidia challeng

60 ia, and peribronchial fibrosis compared with nonsensitized mice that received conidia and normal seru

61 are smaller and less fibrotic than those in nonsensitized mice.

62 hilia and significant AHR when compared with nonsensitized mice.

63 ot observed in A-Tg grafts transplanted into nonsensitized mice.

64 challenged through the airways compared with nonsensitized mice.

65 in skin challenge sites of Ag-sensitized vs nonsensitized mice.

66 the OVA-sensitized and ragweed-challenged or nonsensitized mice.

67 ly elevated at days 3 and 7 after conidia in nonsensitized mice.

68 Compared to nonsensitized monkeys, there was a fourfold reduction in

69 wheeze were significant in children born to nonsensitized mothers (any IgE <0.35 kU/L) but not in th

70 In the lungs of nonsensitized naive mice, IL-33-responsive cells were id

71 Nonsensitized (naive) and sensitized allograft recipient

72 The study includes 189 consecutive nonsensitized, non-HLA-identical patients who received a

73 ectable P-sIgG4 levels and POIT but not from nonsensitized nonallergic children.

74 108 patients with PA, 77 PS patients, and 43 nonsensitized nonallergic subjects) were studied.

75 n allergic (n = 79), sensitized (n = 40) and nonsensitized, nonallergic (n = 37) infants by multiplex

76 peripheral blood mononuclear cells (PBMC) of nonsensitized, 'not-yet' sensitized or sensitized childr

77 Notably, nonsensitized obese mice already exhibited increased lun

78 e in the core of sensitized rats, but not of nonsensitized or control rats.

79 s persulfate and silver nitrate solution the nonsensitized particles evolve oxygen with initial rates

80 %-5.5%) among sensitized patients than among nonsensitized patients (1.6%-3.2%, P<0.001).

81 Pooled normal human AB sera and sera from nonsensitized patients (n=3) served as negative control.

82 d reduced cumulative rejections to levels in nonsensitized patients (P=0.003).

83 Records of nonsensitized patients (panel reactive antibodies [PRA]

84 FD of a zero-antigen mismatch was 0.046% for nonsensitized patients and 0.009% for highly sensitized

85 However, the survival benefit to nonsensitized patients is real and long lasting and will

86 (15-30 mg, 1 dose, subcutaneous), whereas 35 nonsensitized patients received anti-IL-2R.

87 ctional outcomes in HS pediatric patients as nonsensitized patients receiving anti-IL-2R induction.

88 We randomly assigned 55 nonsensitized patients undergoing a first cardiac transp

89 s (95% confidence interval [CI], 47-135) for nonsensitized patients versus 151 months (95% CI, 4 to i

90 red with those in A fumigatus-sensitized and nonsensitized patients with CF without ABPA.

91 AT discriminates A fumigatus-sensitized from nonsensitized patients with CF.

92 mass index in A fumigatus-sensitized but not nonsensitized patients with CF.

93 es greater than 85% and 50 randomly selected nonsensitized patients with PRA values less than 3%.

94 IgG isolated from normal AB serum and three nonsensitized patients, which was depleted of XNA (HLA-I

95 identify more suitably mismatched donors for nonsensitized patients.

96 herapy and subsequently approximated that in nonsensitized patients.

97 y Luminex) have worse outcomes compared with nonsensitized patients.

98 0.4 (95% CI, 0.1-2.2) for sensitized versus nonsensitized patients.

99 ssful re-administration may have occurred in nonsensitized patients.

100 nsitized patients and from 5.4% to 19.6% for nonsensitized patients.

101 uced waiting time and mortality to levels in nonsensitized patients.

102 All kidneys were placed in primary, nonsensitized (peak PRA = 7.9+/-5.6%) adult (41.6+/-16 y

103 immunosuppression with RATG, FK, and MMF for nonsensitized primary kidney or kidney/pancreas transpla

104 Trial was a randomized, prospective study of nonsensitized primary recipients of living donor kidney

105 Nonsensitized primary renal allograft patients (n = 157)

106 nd AMR (32 and 38%) at 3 years compared with nonsensitized recipients (28 and 20%) (P=0.23 and 0.0001

107 loantibody were equivalent in sensitized and nonsensitized recipients 6 weeks after transplantation.

108 f de novo alloantibodies in immunosuppressed nonsensitized recipients and absence of donor HLA-specif

109 Seven nonsensitized recipients of living-donor kidneys were tr

110 to estimated half-lives of 10.3 years among nonsensitized recipients versus 7.8 years among sensitiz

111 trated to confer donor-specific tolerance in nonsensitized recipients, but has not been evaluated in

112 g is to control alloreactive host T cells in nonsensitized recipients, strikingly, none of the strate

113 t higher risk for Ab-mediated rejection than nonsensitized recipients, yet little is known about the

114 after transplantation in both sensitized and nonsensitized recipients.

115 the waiting list with outcomes comparable to nonsensitized recipients.

116 nsfer of anti-A antibody and complement into nonsensitized recipients.

117 asuring serum concentrations, as well as six nonsensitized sera with ATG added in vitro.

118 response to Der f 1 allergen (sensitized vs nonsensitized) to inform a gene-environment study of dus

119 Confocal images of nonsensitized tracheas showed slight fluorescence for P2

120 ransplanted into three groups of recipients: nonsensitized wild type, alloantigen-sensitized wild-typ

121 om mouse work is responsible for symptoms in nonsensitized workers.

122 d DCs (BMDCs) were adoptively transferred to nonsensitized WT mice.

123 ing hearts from A-Tg mice into sensitized or nonsensitized WT mice.